Pycnogenol Maintains Strong Antioxidant Protection and Vision

This is part of our ongoing The Best Kept Secrets to Healthy Aging spotlight. Each day, we will be posting some of the great information that’s packed into our book, The Best Kept Secrets to Healthy Aging.

Today’s topic:
Pycnogenol Maintains Strong Antioxidant Protection and Vision

Enormous numbers of free radicals are produced within the eye (especially the retina) during the chemical conversion of light to sight. If free radical production remains unopposed, the normal processes of vision can lead to free radical overload, causing damage to the retina and cornea, which are particularly sensitive to oxidative damage. For this reason, structural components of the eyes are naturally rich in antioxidant nutrients. Often, these antioxidant stores may decline with normal aging, leading to changes in eye health. Pycnogenol’s antioxidant abilities serve as an important buttress by shielding the eyes from the effects of excessive oxidative stress.

In research published recently in the Journal of Ocular Pharmacology and Therapeutics, supplemental Pycnogenol increased the activities of several antioxidant enzymes within the retinas of rats whose eyes were in a highly oxidizing environment.3 Since Pycnogenol was effective in animals. It is likely that Pycnogenol will also have protective properties in healthy humans. Previous research had shown that Pycnogenol protected fat molecules within the retina from oxidation by the free radicals produced during the visual cycle. By supporting retinal health, Pycnogenol® was shown to be a very powerful promoter of healthy eyes. In fact, research shows that dietary supplementation with 50 mg of Pycnogenol three times daily enhances retinal function and promotes visual acuity in the eyes of adult men and women, thus supporting healthy ocular function.

Next Best Kept Secrets to Healthy Aging topic:
More on Pycnogenol

References:
3. Dene BA, Maritim AC, Sanders RA, Watkins JB 3rd. Effects of antioxidant treatment on normal and diabetic rat retinal enzyme activities. J Ocul Pharmacol Ther 2005;21:28-35.


Leave a Reply